id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-342979-pvewvmmf	Martínez-del Río, Jorge	Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection	2020-11-12		.txt	text/plain	4398	233	50	Conclusions RAS inhibitor treatment prior to admission in patients with COVID-19 respiratory infection was associated with lower risk of the primary composite endpoint and did not show neither impact on mortality nor need for invasive mechanical ventilation, even if these drugs were prescribed during hospitalization. The objective of this study is to evaluate the influence of ACEIs and ARBs (prescribed prior to admission and/or administered during hospitalisation) on the prognosis of patients admitted for COVID-19 with respiratory involvement at the General University Hospital of Ciudad Real (HGUCR), Spain, a provincial reference center. In the present study, the influence of prescribing ACEI or ARB drugs prior to admission and during hospitalisation on the in-hospital prognosis of patients with respiratory infection caused by SARS-CoV-2 has been evaluated. Patients with respiratory infection caused by SARS-CoV-2 who were admitted to the HGUCR and with a previous prescription of ACEIs or ARBs had a lower risk of developing the combined primary event.	./cache/cord-342979-pvewvmmf.txt	./txt/cord-342979-pvewvmmf.txt